Timeline Slightly Delayed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Lannett Company, Inc. (NYSE: LCI) today provided an update on the clinical advancement and development of its biosimilar insulin aspart and.

Robert jaffeNovo nordiskCompany formLannett companyBiosimilar biological product developmentPrnewswire lannett company incLannett company incRobert jaffe coAnnounces positive animalInsulin aspart versusPivotal trial resultsInsulin glargine nearly completedTimeline slightly delayedPotential launch timing remainsTim crewInvestigational new drug